Rewind two years, and astaxanthin was the hottest nutraceutical in town, with sales “skyrocketing” following a slot on Dr Oz in which Dr Joseph Mercola described the potent red antioxidant as the “number one supplement you’ve never heard of that you should...
Astaxanthin for human nutrition is still a saving grace for
Cyanotech, which has reported that a 27 percent drop in sales for
3Q 2006 compared to the prior year period are down to reduced
orders for spirulina and for NatuRose aquaculture...
Cyanotech has signed a deal with a distribution company in China
that will see its astaxanthin ingredient sold in the promising
market for the first time - for both human nutrition and
aquaculture.
Cyanotech has been threatened with being bumped from Nasdaq's
SmallCap market if its share price does not rise above the minimum
$1.00 for 10 consecutive days before the end of May 2006.
Microalgae producers Cyanotech and Earthrise Nutritionals have
signaled their surprise that spirulina was excluded from a recent
study suggesting that a potential toxin known as BMAA is present in
diverse groups of cyanobacteria,...
The Hawaiian based nutraceutical firm Cyanotech - which makes
natural products from microalgae - has announced a shaky start to
fiscal 2005, despite a recent return to profitability.
Natural astaxanthin produced from algae can help reduce the
symptoms of Carpal Tunnel Syndrome, the ailment also known as
repetitive stress injury which affects users of computers and cash
registers, reports the Hawaii-based group...